伊科德克斯以剂量依赖的方式降低血清:一个病例报告
Marko Karakadze1, Sophia Sugar1, Isaac Teitelbaum1
1Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
概括
在腹腔透析中使用icodextrin (ICO) 可能会导致低血. 本案例研究表明,ICO的剂量与低血症的严重程度之间存在直接关系,建议减少剂量作为管理策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床化学 临床化学
背景情况:
- 伊科德克斯 (ICO) 是一种常见的透剂,用于腹腔透析 (PD).
- 低血压 (低血清) 是与ICO相关的已知不良事件,但剂量反应关系尚未明确确确立.
研究的目的:
- 为了研究Icodextrin (ICO) 管理和在接受腹腔透析 (PD) 的患者中发展低血的潜在剂量效应关系.
主要方法:
- 一份病例报告,详细介绍了患有末期脏病 (ESKD) 的患者在PD.
- 随着时间的推移,血清水平被监测到与每日不同剂量的Icodextrin (ICO) 和乳糖交换有关.
- 在血清水平和每日ICO总剂量之间进行了相关性分析.
主要成果:
- 患者仅在ICO使用期间才出现复发性低血症,严重程度与每日ICO剂量 (高达3L) 相对应.
- 在使用乳糖交换时维持了正常血症,并在停止ICO时正常化.
- 在血清水平和每日ICO总剂量之间观察到强烈的相关性 (R2 = 0.737).
结论:
- 伊科德克斯 (ICO) 诱导的低血症的严重程度与服用的剂量直接成比例.
- 对于患有低血症的PD患者,降低ICO剂量可能是完全停止治疗的可行替代方案.
相关概念视频
Antihypertensive Drugs: Action of Diuretics
874
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
874
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics
773
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
773
Antihypertensive Drugs: Thiazide-Class Diuretics
880
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
880
Renal Failure: Dose Adjustments
161
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
161
Drugs for Treatment of Diarrhea-Predominant IBS
299
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
299


